VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS). Use of VYKAT XR is contraindicated in patients ...

Patients without chest pain were significantly older than those with typical symptoms. They were more likely to be women and to have a history of hypertension, diabetes, or heart failure ...

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to U.S. patients. The Prader-Willi Syndrome Association USA estimates that ...

The Prader-Willi Syndrome Association USA estimates that PWS occurs in one ... and cardiovascular disease. Use of VYKAT XR is contraindicated in patients who have a known hypersensitivity to diazoxide ...

The Prader-Willi Syndrome Association USA estimates that ... and cardiovascular disease. Use of VYKAT XR is contraindicated in patients who have a known hypersensitivity to diazoxide, other ...

Unstable angina is when you experience unexpected chest pain, and it usually occurs while you're resting. Unstable angina is a type of acute coronary syndrome, as are heart attacks, meaning it can ...

Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide whether patients presenting with acute chest pain are having a heart attack.

Admission rates among patients presenting to emergency departments with possible acute coronary ... emergency department with chest pain and possible acute coronary syndrome.

without chest and back pain, pericardial fluid, or aortic disease progression. This clinical image illustrates high utility of TTE, enriched with the PV views, in aortic syndromes, as the fastest and ...

some people may experience chest pain and shortness of breath — the result of a condition known colloquially as “broken heart syndrome.” The syndrome, which doctors formally call takotsubo ...